Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


MARKSANS PHARMA. Gains 5%; BSE HEALTHCARE Index Up 0.8%
Thu, 14 Nov 9:26

MARKSANS PHARMA. Gains 5%; BSE HEALTHCARE Index Up 0.8%Image source: Eoneren/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 5% and is presently trading at Rs 315.8.

Meanwhile, the BSE HEALTHCARE index is at 42,763.0 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are Natco Pharma (up 3.3%) and FORTIS HEALTHCARE (up 2.9%).

ASTRAZENECA PHARMA (down 1.9%) and J.B.Chemicals (down 1.0%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 137.9 to Rs 315.8, registering a gain of Rs 177.9 (up 129.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,042.6 to 42,763.0, registering a gain of 47.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 182.3%), SUVEN PHARMACEUTICALS (up 113.8%) and Glenmark Pharma (up 103.1%).

For Investors: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 77,793.0 (up 0.1%).

The top gainers among the BSE Sensex today are HCl Tech. (up 0.9%) and Sun Pharma (up 0.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 23,615.1 (up 0.2%). Eicher Motor and Hindalco are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,793.0, registering a gain of 12,533.6 points (up 19.2%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 16.6% YoY to Rs 978 million for the quarter ended September 2024, compared to a profit of Rs 839 million a year ago. Net sales rose 20.8% to Rs 6,419 million during the period as against Rs 5,312 million in July-September 2023.

For the year ended March 2024, MARKSANS PHARMA. reported 18.7% increase in net profit to Rs 3,149 million compared to net profit of Rs 2,653 million during FY23. Revenue of the company grew 17.6% to Rs 21,774 million during FY24.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 41.2.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 5%; BSE HEALTHCARE Index Up 0.8%". Click here!